Cost-Effectiveness of Cardiac Resynchronization Therapy in Patients with Symptomatic Heart Failure

(Downloading may take up to 30 seconds. If the slide opens in your browser, select File -> Save As to save it.)

Click on image to view larger version.

Figure 3. For the base-case point estimate ( ), incremental costs = $30 252 and incremental effect = 0.282 quality-adjusted life-year ( ).
Figure 3. For the base-case point estimate ( ), incremental costs = $30 252 and incremental effect = 0.282 quality-adjusted life-year ( ). Distribution of incremental costs versus incremental effects for cardiac resynchronization therapy versus medical therapy.white XQALY

This Article

  1. First published July 12, 2004, Ann Intern Med September 7, 2004 vol. 141 no. 5 343-351
  1. AbstractFREE
  2. Figures
  3. Full Text
  4. Full Text (PDF)

Current Issue

  1. March 16, 2010, 152 (6)
  1. Alert me to current issues